Related Experiment Video
Updated: Jun 25, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A
Benjamin D Horne1,2,3, Nipun Atreja4, John Venditto4
1Intermountain Medical Center Heart Institute, Salt Lake City, UT 84107, USA.
Insights
Predictors of major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI) were identified. A new model helps assess patient risk and improve post-PCI care outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Health Outcomes Research
Background:
- Patient outcomes following percutaneous coronary intervention (PCI) have significantly improved.
- Contemporary predictors of major adverse cardiovascular events (MACE) post-PCI require updated evaluation.
- Risk stratification is crucial for optimizing post-PCI patient care.
Purpose of the Study:
- To identify contemporary predictors of MACE after PCI.
- To develop a parsimonious risk prediction model for post-PCI MACE.
- To evaluate the effectiveness of current treatments in mitigating MACE.
Main Methods:
- Utilized the Cardiovascular Patient-Level Analytical Platform (CLiPPeR) dataset, integrating CathPCI Registry and national claims data.
- Analyzed longitudinal outcomes (2-6 years) for 1,450,787 patients undergoing PCI between 2012-2015.
- Employed Cox regression, landmarked 28 days post-PCI, to assess clinical and procedural predictors of MACE.
Main Results:
- 12.4% of patients experienced MACE. Key predictors included cardiogenic shock, cardiac arrest, four-vessel disease, and chronic kidney disease (HR ≥ 1.50).
- Other significant predictors: in-hospital stroke, three-vessel disease, anemia, heart failure, and STEMI presentation.
- Discharge medications (aspirin, P2Y12 inhibitor, lipid-lowering) and revascularization were protective (HR ≤ 0.67).
Conclusions:
- Identified key clinical and procedural predictors of longitudinal MACE risk in a national US post-PCI population.
- Developed a parsimonious risk model that efficiently encapsulates these predictors.
- Findings can inform care process assessment to further enhance post-PCI outcomes.
Abstract:
Background: Patient outcomes after percutaneous coronary intervention (PCI) have improved over the last 30 years due to better techniques, therapies, and care processes. This study evaluated contemporary predictors of post-PCI major adverse cardiovascular events (MACE) and summarized risk in a parsimonious risk prediction model. Methods: The Cardiovascular Patient-Level Analytical Platform (CLiPPeR) is an observational dataset of baseline variables and longitudinal outcomes from the American College of Cardiology's CathPCI Registry® and national claims data. Cox regression was used to evaluate 2-6 years of patient follow-up (mean: 2.56 years), ending in December 2017, after index PCI between 2012 and 2015 (N = 1,450,787), to examine clinical and procedural predictors of MACE (first myocardial infarction, stroke, repeat PCI, coronary artery bypass grafting, and mortality). Cox analyses of post-PCI MACE were landmarked 28 days after index PCI. Results: Overall, 12.4% (n = 179,849) experienced MACE. All variables predicted MACE, with cardiogenic shock, cardiac arrest, four diseased coronary vessels, and chronic kidney disease having hazard ratios (HRs) ≥ 1.50. Other major predictors of MACE were in-hospital stroke, three-vessel disease, anemia, heart failure, and STEMI presentation. The index revascularization and discharge prescription of aspirin, P2Y12 inhibitor, and lipid-lowering medication had HR ≤ 0.67. The primary Cox model had c-statistic c = 0.761 for MACE versus c = 0.701 for the parsimonious model and c = 0.752 for the parsimonious model plus treatment variables. Conclusions: In a nationally representative US sample of post-PCI patients, predictors of longitudinal MACE risk were identified, and a parsimonious model efficiently encapsulated them. These findings may aid in assessing care processes to further improve care post-PCI outcomes.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...